Targeting β2-adrenergic receptor reduces UV-induced cutaneous damage and inflammation in a murine model
{{output}}
Preclinical studies demonstrated that the β-adrenergic receptor antagonists (β-blockers) inhibit skin damage and cancer development induced by ultraviolet (UV) radiation, but the mechanism remains unknown. β2-adrenergic receptor (β2-AR) is the predominant ... ...
